drugset / Trial / NCT01477242

The Effect of Ondansetron During Intramuscular Ketamine Use in Children: A Trial in Emergency Department

NCT01477242

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the anti-emetic effect of oral ondansetron. For this evaluation, the investigators will perform a multi-center, double-blind, placebo-controled, randomized study. The investigators assumption is that oral ondansetron prior to intramuscular ketamine will reduce the occurrence of ketamine-induced vomiting.

Timeline

Start
2011-11
Primary completion
2012-05
Completion
2012-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Ondansetron Other / unclassified 2 mg Oral
Subject Ondansetron Other / unclassified 4 mg Oral

Indications

No indication recorded.